Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer

by Lorusso, Vito, Latorre, Agnese, Giotta, Francesco
Published in J Oncol (2020)

Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)

by Lorusso, Vito, Russo, Anna, Giotta, Francesco, Codega, Paolo
Published in Core Evid (2020)

Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients

by Saponaro, Concetta, Scarpi, Emanuela, Zito, Francesco Alfredo, Giotta, Francesco, Silvestris, Nicola, Mangia, Anita
Published in Cancers (Basel) (2019)

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics

by Petroni, Stella, Caldarola, Lucia, Scamarcio, Rachele, Giotta, Francesco, Latorre, Agnese, Mangia, Anita, Simone, Giovanni
Published in Oncol Lett (2016)

NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients

by Mangia, Anita, Scarpi, Emanuela, Partipilo, Giulia, Schirosi, Laura, Opinto, Giuseppina, Giotta, Francesco, Simone, Giovanni
Published in Oncotarget (2017)

Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients

by Schirosi, Laura, Saponaro, Concetta, Giotta, Francesco, Popescu, Ondina, Pastena, Maria Irene, Scarpi, Emanuela, Mangia, Anita
Published in Transl Oncol (2019)

The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

by Russo, Francesco, Linsalata, Michele, Clemente, Caterina, D’Attoma, Benedetta, Orlando, Antonella, Campanella, Giovanna, Giotta, Francesco, Riezzo, Giuseppe
Published 2013

Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel

by Ranieri, Girolamo, Marech, Ilaria, Porcelli, Mariangela, Giotta, Francesco, Palmiotti, Gennaro, Laricchia, Giuseppe, Fazio, Vito, Gadaleta, Cosmo Damiano
Published in Oncotarget (2017)

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

by Mangia, Anita, Saponaro, Concetta, Vagheggini, Alessandro, Opinto, Giuseppina, Centonze, Matteo, Vicenti, Chiara, Popescu, Ondina, Pastena, Maria, Giotta, Francesco, Silvestris, Nicola
Published in Cancers (Basel) (2019)

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma

by Saponaro, Concetta, Vagheggini, Alessandro, Scarpi, Emanuela, Centonze, Matteo, Catacchio, Ivana, Popescu, Ondina, Pastena, Maria Irene, Giotta, Francesco, Silvestris, Nicola, Mangia, Anita
Published in J Exp Clin Cancer Res (2018)

Administration of Angiotensin-Converting Enzyme Inhibitors and β-Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotecti...

by Oliva, Stefano, Cioffi, Giovanni, Frattini, Silvia, Simoncini, Edda Lucia, Faggiano, Pompilio, Boccardi, Lidia, Pulignano, Giovanni, Fioretti, Agnese Maria, Giotta, Francesco, Lestuzzi, Chiara, Maurea, Nicola, Sabatini, Silvia, Tarantini, Luigi
Published 2012

A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer....

by Vici, Patrizia, Colucci, Giuseppe, Giotta, Francesco, Sergi, Domenico, Filippelli, Gianfranco, Perri, Pasquale, Botti, Claudio, Vizza, Enrico, Carpino, Armando, Pizzuti, Laura, Latorre, Agnese, Giannarelli, Diana, Lopez, Massimo, Di Lauro, Luigi
Published 2011

Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study

by Fanizzi, Annarita, Pomarico, Domenico, Paradiso, Angelo, Bove, Samantha, Diotaiuti, Sergio, Didonna, Vittorio, Giotta, Francesco, La Forgia, Daniele, Latorre, Agnese, Pastena, Maria Irene, Tamborra, Pasquale, Zito, Alfredo, Lorusso, Vito, Massafra, Raffaella
Published in Cancers (Basel) (2021)

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI

by La Forgia, Daniele, Vestito, Angela, Lasciarrea, Maurilia, Comes, Maria Colomba, Diotaiuti, Sergio, Giotta, Francesco, Latorre, Agnese, Lorusso, Vito, Massafra, Raffaella, Palmiotti, Gennaro, Rinaldi, Lucia, Signorile, Rahel, Gatta, Gianluca, Fanizzi, Annarita
Published in J Pers Med (2021)

Early Prediction of Breast Cancer Recurrence for Patients Treated with Neoadjuvant Chemotherapy: A Transfer Learning Approach on DCE-MRIs

by Comes, Maria Colomba, La Forgia, Daniele, Didonna, Vittorio, Fanizzi, Annarita, Giotta, Francesco, Latorre, Agnese, Martinelli, Eugenio, Mencattini, Arianna, Paradiso, Angelo Virgilio, Tamborra, Pasquale, Terenzio, Antonella, Zito, Alfredo, Lorusso, Vito, Massafra, Raffaella
Published in Cancers (Basel) (2021)

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

by Clavarezza, Matteo, Mustacchi, Giorgio, Casadei Gardini, Andrea, Del Mastro, Lucia, De Matteis, Andrea, Riccardi, Ferdinando, Adamo, Vincenzo, Aitini, Enrico, Amoroso, Domenico, Marchetti, Paolo, Gori, Stefania, Carrozza, Francesco, Maiello, Evaristo, Giotta, Francesco, Dondi, Davide, Venturini, Marco
Published 2012

A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results

by Massafra, Raffaella, Latorre, Agnese, Fanizzi, Annarita, Bellotti, Roberto, Didonna, Vittorio, Giotta, Francesco, La Forgia, Daniele, Nardone, Annalisa, Pastena, Maria, Ressa, Cosmo Maurizio, Rinaldi, Lucia, Russo, Anna Orsola Maria, Tamborra, Pasquale, Tangaro, Sabina, Zito, Alfredo, Lorusso, Vito
Published in Front Oncol (2021)

Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II tria...

by Orlando, Laura, Lorusso, Vito, Giotta, Francesco, Di Maio, Massimo, Schiavone, Paola, Fedele, Palma, Quaranta, Annamaria, Caliolo, Chiara, Ciccarese, Mariangela, Cinefra, Margherita, Romito, Sante, Pisconti, Salvatore, Prete, Salvatore del, Aieta, Michele, Rizzi, Daniele, Maiello, Evaristo, Colucci, Giuseppe, Cinieri, Saverio
Published in Breast (2020)

Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes

by Giotta, Francesco, Acito, Luigi, Candeloro, Giampiero, Del Medico, Pietro, Gadaleta-Caldarola, Gennaro, Giordano, Guido, Gueli, Rossana, Lugini, Antonio, Magri, Valentina, Mandarà, Marta, Masci, Giovanna, Pisconti, Salvatore, Pistelli, Mirco, Rizzi, Anna, Salesi, Nello, Schirone, Alessio, Scognamiglio, Giovanni, Tedeschi, Maria, Zucchinelli, Patrizia
Published in Oncologist (2016)

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

by Vici, Patrizia, Pizzuti, Laura, Natoli, Clara, Moscetti, Luca, Mentuccia, Lucia, Vaccaro, Angela, Sergi, Domenico, Di Lauro, Luigi, Trenta, Patrizia, Seminara, Patrizia, Santini, Daniele, Iezzi, Laura, Tinari, Nicola, Bertolini, Ilaria, Sini, Valentina, Mottolese, Marcella, Giannarelli, Diana, Giotta, Francesco, Maugeri-Saccà, Marcello, Barba, Maddalena, Marchetti, Paolo, Michelotti, Andrea, Sperduti, Isabella, Gamucci, Teresa
Published 2014